Home/Filings/4/0001127602-18-026852
4//SEC Filing

Gary M. Huff 4

Accession 0001127602-18-026852

CIK 0000920148other

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 10:21 AM ET

Size

8.9 KB

Accession

0001127602-18-026852

Insider Transaction Report

Form 4
Period: 2018-09-04
Gary M. Huff
CEO, LabCorp Diagnostics
Transactions
  • Exercise/Conversion

    Common Stock

    2018-09-04+1531,918.616 total
  • Exercise/Conversion

    Restricted Stock Unit

    2018-09-0415311,068 total
    Common Stock (153 underlying)
  • Tax Payment

    Common Stock

    2018-09-04$169.15/sh69$11,6711,849.616 total
Footnotes (5)
  • [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
  • [F2]Amount includes 155.2506 shares acquired on June 29, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
  • [F3]Stock withholding to satisfy tax withholding obligations.
  • [F4]The Restricted Stock Units vest in three equal annual installments beginning on 9/1/17.
  • [F5]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Issuer

LABORATORY CORP OF AMERICA HOLDINGS

CIK 0000920148

Entity typeother
IncorporatedNC

Related Parties

1
  • filerCIK 0001702387

Filing Metadata

Form type
4
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 10:21 AM ET
Size
8.9 KB